PROCEPT BioRobotics Corporation (PRCT)
NasdaqGM · USD · Healthcare · Medical Devices
$19.80 (-0.15%) as of
Key statistics
- Market cap
- 1.13B
- Forward P/E
- -16.90
- EPS (TTM)
- -1.94
- Dividend yield
- 0.00%
- 52-week range
- 16.67 – 38.11
- Beta
- 0.92
- Revenue (TTM)
- 337.34M
- Profit margin
- -32.53%
- Analyst target
- $22.25
- Volume
- 708.66k
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- San Jose, CA, United States
- Employees
- 888
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.